Vifor Fresenius Medical Care Renal Pharma (Vfmcrp) And Cara Therapeutics, Inc. Announced That They Have Received Approval For Kapruvia From The Swiss Agency For Therapeutic Products (Swissmedic). Kapruvia Will Be The First Therapy Available For The Treatment Of Moderate-To-Severe Pruritus Associated With Chronic Kidney Disease In Adult Haemodialysis Patients. Swissmedic Approval For Kapruvia Follows Approvals By The Us Food And Drug Administration, By The European Medicines Agency, By The Uk Medicines And Healthcare Products Regulatory Agency, As Well As By Health Canada.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!